Amgen – Amgen Inc. stock underperforms Wednesday when compared to competitors
Shares of Amgen Inc.
AMGN,
dropped 0.39% to $248.12 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index
SPX,
rising 0.15% to 4,079.95 and the Dow Jones Industrial Average
DJIA,
rising 0.05% to 33,446.26. This was the stock’s second consecutive day of losses. Amgen Inc. closed $28.57 below its 52-week high ($276.69), which the company achieved on January 28th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson
JNJ,
rose 0.13% to $163.61, Roche Holding AG Part. Cert.
RHHVF,
fell 0.10% to $327.09, and Pfizer Inc.
PFE,
fell 0.39% to $35.91. Trading volume (1.6 M) remained 1.2 million below its 50-day average volume of 2.8 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
